Evidence map›Paper›PMID 33613523›Full record

ArticleFrontiers in immunology2020

Noriko Shinjyo, Kenji Hikosaka, Yasutoshi Kido, Hiroki Yoshida, Kazumi Norose

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Noriko ShinjyoDepartment of Infection and Host Defense, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kenji HikosakaDepartment of Infection and Host Defense, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yasutoshi KidoDepartment of Parasitology & Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Hiroki YoshidaDivision of Molecular and Cellular Immunoscience, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga, Japan.
Kazumi NoroseDepartment of Infection and Host Defense, Graduate School of Medicine, Chiba University, Chiba, Japan.
Chiba University · JPOsaka City University · JPSaga University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Complement Pathway, AlternativeAnimalsBrainCells, CulturedComplement Factor BDisease Models, AnimalHost-Parasite InteractionsMaleMiceMice, Inbred C57BLMicrogliaReceptor, Anaphylatoxin C5aReceptors, G-Protein-CoupledSignal TransductionTime FactorsToxoplasmaC3a-derived anaphylatoxin receptor, mouseC5ar1 protein, mouseComplement Factor BReceptor, Anaphylatoxin C5aReceptors, G-Protein-Coupledbraincerebral toxoplasmosiscomplementinfectionmicrogliaToxoplasma

Identifiers

PMID33613523
PMCPMC7892429
OpenAlexW3128285708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.